Privium Fund Management (UK)’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-51,000
Closed -$994K 125
2021
Q4
$994K Hold
51,000
0.78% 25
2021
Q3
$998K Buy
+51,000
New +$1.94M 1.07% 25

Other funds holding CELL

Privium Fund Management (UK)'s CELL Position: Q1 2022 in Review

Privium Fund Management (UK) sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 51,000 shares — an estimated $994K sold.

Privium Fund Management (UK) first reported a position in CELL in Q3 2021 and held it in 2 quarters. The position peaked at $998K in Q3 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.

  • Privium Fund Management (UK) reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Privium Fund Management (UK) sold 51,000 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $994K.
  • Privium Fund Management (UK) first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Privium Fund Management (UK)'s PhenomeX Inc. Common Stock position peaked at $998K in Q3 2021.
  • 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.

Based on Privium Fund Management (UK)'s 13F filing for Q1 2022, filed 10 May 2022.